Preclinical outcomes of Intratumoral Modulation Therapy for glioblastoma.

Sci Rep · 2018 · PMC5940838 · PMID 29740075

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The difference in GBM cell viability between TMZ and IMT (P < 0.001), and between TMZ (P < 0.001) or IMT (P < 0.001) and the combined TMZ + IMT treatments were all highly significant.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.